OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Exosome therapeutics for non-small cell lung cancer tumorigenesis
Niloufar Orooji, Manouchehr Fadaee, Tohid Kazemi, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7
Niloufar Orooji, Manouchehr Fadaee, Tohid Kazemi, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7
Showing 7 citing articles:
Advancements in Colorectal Cancer Immunotherapy: From CAR-T Cells to Exosome-Based Therapies
Sepideh Arabi, Manouchehr Fadaee, Tohid Kazemi, et al.
Journal of drug targeting (2025), pp. 1-23
Closed Access | Times Cited: 1
Sepideh Arabi, Manouchehr Fadaee, Tohid Kazemi, et al.
Journal of drug targeting (2025), pp. 1-23
Closed Access | Times Cited: 1
Cell-based Immunotherapy in Esophageal Cancer
Masoud Lahouty, Amirhossein Soleymanzadeh, Sohrab Kazemi, et al.
Journal of drug targeting (2025), pp. 1-19
Closed Access | Times Cited: 1
Masoud Lahouty, Amirhossein Soleymanzadeh, Sohrab Kazemi, et al.
Journal of drug targeting (2025), pp. 1-19
Closed Access | Times Cited: 1
Exosomes derived from natural killer cells: transforming immunotherapy for aggressive breast cancer
Abdulmalik Saleh Alfawaz Altamimi, M. Arockia Babu, Muhammad Afzal, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access
Abdulmalik Saleh Alfawaz Altamimi, M. Arockia Babu, Muhammad Afzal, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access
Functional tumor-derived exosomes in NSCLC progression and clinical implications
Yuxin Gao, Jun Xie, Zhenya Yang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Yuxin Gao, Jun Xie, Zhenya Yang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Novel therapeutic approaches for non-small cell lung cancer: an updated view
Niloufar Orooji, Shabnam Babaei, Manouchehr Fadaee, et al.
Journal of drug targeting (2025), pp. 1-29
Closed Access
Niloufar Orooji, Shabnam Babaei, Manouchehr Fadaee, et al.
Journal of drug targeting (2025), pp. 1-29
Closed Access
Smart nanoparticle delivery of cancer vaccines enhances tumor immune responses: a review
Jihua Qiu, Chenghu Wu
Frontiers in Nanotechnology (2025) Vol. 7
Open Access
Jihua Qiu, Chenghu Wu
Frontiers in Nanotechnology (2025) Vol. 7
Open Access
Exosome-driven nano-immunotherapy: revolutionizing colorectal cancer treatment
Masoud Lahouty, Manouchehr Fadaee, Dariush Shanehbandi, et al.
Molecular Biology Reports (2024) Vol. 52, Iss. 1
Closed Access | Times Cited: 3
Masoud Lahouty, Manouchehr Fadaee, Dariush Shanehbandi, et al.
Molecular Biology Reports (2024) Vol. 52, Iss. 1
Closed Access | Times Cited: 3
Extracellular Vesicles and Their Applications in Tumor Diagnostics and Immunotherapy
Scott Strum, Valentina Evdokimova, Laszlo Radvanyi, et al.
Cells (2024) Vol. 13, Iss. 23, pp. 2031-2031
Open Access
Scott Strum, Valentina Evdokimova, Laszlo Radvanyi, et al.
Cells (2024) Vol. 13, Iss. 23, pp. 2031-2031
Open Access
